News From the Sarthy Lab

Insight into how cancer medicines affect cells could lead Seattle Children’s Dr. Jay Sarthy to a safer form of common chemotherapies.

Dr. Sarthy's symposium presentation, “Epigenetic Activities of Anthracycline Derivatives Mitigate Toxicity and Overcome Resistance in Sarcomas,” highlighted collaboration with WSU researchers already underway and the potential of cross-species research.

Newman named to prestigious four-person cohort of Damon Runyon Cancer Research Foundation’s intensive post-baccalaureate program for future cancer research leaders.

Brotman Baty Institute

Undergraduate Research Student Carter Zivin’s lymphoma and leukemia research was funded by Alex’s Lemonade Stand’s Pediatric Oncology Student Training (POST) Program.